Remove Data Remove Extraction Remove Hemp
article thumbnail

U.S. Hemp Roundtable Statement Regarding FDA NDIN Rejection Letters

Cannabis Law Report

Hemp Roundtable is deeply disappointed to witness FDA’s rejection of two dietary ingredient notifications (NDINs) recently submitted for full spectrum hemp extracts. (WASHINGTON) – The U.S. USHR-Statement-on-FDA-NDIN-Rejection-Letters.

Hemp 105
article thumbnail

June 24: Carbon Credits & Hemp

Cannabis Law Report

PanXchange has the leading trading and benchmark pricing data in both the US hemp market and the 120 million-ton specialty sand market for US oil and gas extraction. Julie Lerner is the Founder and CEO of PanXchange, a web-based trading and price discovery platform for physical commodities.

Hemp 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Washington’s Hemp Plan

Canna Law Blog

On November 20th, the Washington State Department of Agriculture (“WSDA”) released the hemp cultivation plan (the “Plan”) that it intends to submit to the US Department of Agriculture (“USDA”) along with a corresponding set of hemp regulations (“Hemp Rules”). This post will provide an overview of Washington’s hemp plan.

Hemp 117
article thumbnail

Hemp Prices Continue To Fall

Cannabis Law Report

It was also a notable, if not promising month for hemp. Hemp Benchmarks , a division of New Leaf Data Services and leading provider of financial, business, and industry data for the North American hemp markets, recently issued its report for July, which touches on some of the most high-profile talking points of the hemp market to date.

Hemp 105
article thumbnail

Avicanna Completes First Commercial Export of Aureus Branded Full Spectrum Psychoactive CBD Cannabis Extracts to Brazil

Cannabis Law Report

This initial export to Brazil marks Avicanna ’s first commercial export of psychoactive Cannabis Extracts into the emerging Brazilian medicinal cannabis market and the delivery of the initial purchase order from the previously announced three (3) year master supply agreement. RHO Phyto is the first medical formulary of advanced “Cannabis 2.0”

article thumbnail

CRN Denounces FDA Rejection of New Dietary Ingredient Notifications for Hemp Extract Containing CBD, Urges Congress to Act

Cannabis Law Report

The following is a statement from CRN President & CEO Steve Mister: “CRN is extremely disappointed to learn that FDA rejected NDI notifications for full-spectrum hemp extract containing CBD submitted earlier this year by supplement manufacturers Charlotte’s Web and Irwin Naturals.

article thumbnail

Avicanna Completes First Commercial Export of Aureus™ Branded THC Extracts to Austria and Welcomes Colombian Government’s Progressive New Regulation on Cannabis

Cannabis Law Report

This initial export to Austria marks Avicanna’s first commercial export of psychoactive THC Cannabis Extracts into the emerging European medicinal cannabis market. Initial shipment of THC extracts into the European Union.